Baxter International (MEX:BAX) Cyclically Adjusted Revenue per Share: MXN447.62 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:BAX Baxter International Inc MEX:BAX
51 GF Score
Price MXN427.50
GF Value MXN542.71
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Baxter International Cyclically Adjusted Revenue per Share?

Baxter International MEX:BAX 51 Cyclically Adjusted Revenue per Share is MXN447.62 as of Jun. 2026. GuruFocus rates MEX:BAX with a GF Score™ of 51/100 and a GF Value™ of MXN542.71 (Modestly Undervalued). The stock has 9 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Baxter International's adjusted revenue per share for the three months ended in Jun. 2026 was MXN99.709. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN447.62 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Baxter International's average Cyclically Adjusted Revenue Growth Rate was 2.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 1.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 1.80% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Baxter International was 7.50% per year. The lowest was -4.00% per year. And the median was 1.40% per year.

As of today (2026-08-01), Baxter International's current stock price is MXN427.50. Baxter International's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was MXN447.62. Baxter International's Cyclically Adjusted PS Ratio of today is 0.96.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Baxter International was 4.06. The lowest was 0.63. And the median was 2.68.


Baxter International  (MEX:BAX) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Baxter International's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=427.50/447.62
=0.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Baxter International was 4.06. The lowest was 0.63. And the median was 2.68.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Baxter International Cyclically Adjusted Revenue per Share Related Terms


Baxter International Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Baxter International's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baxter International Cyclically Adjusted Revenue per Share Chart

Baxter International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 493.11 469.57 491.40 502.01 443.45

Baxter International Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 504.52 517.62 443.45 473.49 447.62

MEX:BAX vs ALGN, SOLV, COO: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, Baxter International's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baxter International Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baxter International's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Baxter International's Cyclically Adjusted PS Ratio falls into.


MEX:BAX
51GF Score
Baxter International Inc MEX:BAX
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Baxter International Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Baxter International's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=99.709/333.9520*333.9520
=99.709

Current CPI (Jun. 2026) = 333.9520.

Baxter International Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 89.764 241.428 124.165
201612 99.511 241.432 137.645
201703 84.577 243.801 115.851
201706 84.843 244.955 115.668
201709 88.199 246.819 119.335
201712 98.444 246.524 133.356
201803 88.266 249.554 118.117
201806 102.091 251.989 135.298
201809 94.587 252.439 125.129
201812 103.011 251.233 136.928
201903 98.031 254.202 128.786
201906 104.890 256.143 136.753
201909 108.239 256.759 140.780
201912 111.077 256.974 144.351
202003 127.328 258.115 164.738
202006 121.348 257.797 157.195
202009 126.746 260.280 162.621
202012 122.392 260.474 156.918
202103 117.846 264.877 148.578
202106 121.157 271.696 148.919
202109 131.093 274.310 159.596
202112 116.828 278.802 139.938
202203 145.010 287.504 168.437
202206 142.331 296.311 160.412
202209 144.038 296.808 162.064
202212 -27.071 296.797 -30.460
202303 125.390 301.836 138.732
202306 125.598 305.109 137.471
202309 88.942 307.789 96.502
202312 90.023 306.746 98.007
202403 81.029 312.332 86.638
202406 96.584 314.175 102.664
202409 103.797 315.301 109.937
202412 111.922 315.605 118.428
202503 104.480 319.799 109.104
202506 102.938 322.561 106.573
202509 101.179 324.800 104.030
202512 104.384 324.054 107.572
202603 94.575 330.213 95.646
202606 99.709 333.952 99.709

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN447.62 mean?
Baxter International (MEX:BAX) has a Cyclically Adjusted Revenue per Share of MXN447.62 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Baxter International and its competitors.
Is Baxter International's Cyclically Adjusted Revenue per Share too high?
Baxter International's current Cyclically Adjusted Revenue per Share is MXN447.62. Overall, Baxter International has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Baxter International's Cyclically Adjusted Revenue per Share compare to ALGN and SOLV?
Baxter International's Cyclically Adjusted Revenue per Share of MXN447.62 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Baxter International and its competitors. Baxter International's current Cyclically Adjusted Revenue per Share is MXN447.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baxter International stock overvalued right now?
Based on GuruFocus' analysis, Baxter International (MEX:BAX) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN542.71, compared to a current price of MXN427.50 — trading 21.2% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN447.62. Baxter International's overall GF Score™ is 51/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Baxter International (MEX:BAX), the current Cyclically Adjusted Revenue per Share is MXN447.62 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Baxter International (MEX:BAX) Overvalued in 2026?

Based on GuruFocus' analysis, Baxter International stock appears to be undervalued. The current stock price of MXN427.50 is trading 21.2% below its estimated GF Value™ of MXN542.71. GuruFocus considers Baxter International to be Modestly Undervalued.

Key valuation signals for MEX:BAX:

  • Cyclically Adjusted Revenue per Share: MXN447.62
  • GF Value™: MXN542.71 vs. price of MXN427.50 (21.2% below fair value)
  • GF Score™: 51/100 with 9 warning signs

No single metric tells the full story. See the MEX:BAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Baxter International Business Description

Address One Baxter Parkway, Deerfield, IL, USA, 60015
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
51GF Score

Get the complete analysis for MEX:BAX

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN427.50
Price
MXN542.71
GF Value